CLINICAL_TRIALS
trial_result
· 2017-05-19
Clinical Trial Update: Study on Immunization Schedule of Beijing Tiantan Biological's Measles-mumps-rubella(MMR) Vaccine [Phase 4]
Summary
A Phase 4 trial sponsored by the Centers for Disease Control and Prevention, China, evaluated the immunization schedule for Beijing Tiantan Biological's measles…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centers for Disease Control and Prevention, China | Conditions: Measles, Mumps | Phase 4 | Status: COMPLETED